Trauma Fixation Devices - Medical Devices Pipeline Assessment, 2020

1.1 List of Tables
1.2 List of Figures

2.1 Trauma Fixation Overview

3.1 Trauma Fixation - Pipeline Products by Stage of Development
3.2 Trauma Fixation - Pipeline Products by Segment
3.3 Trauma Fixation - Pipeline Products by Territory
3.4 Trauma Fixation - Pipeline Products by Regulatory Path
3.5 Trauma Fixation - Pipeline Products by Estimated Approval Date
3.6 Trauma Fixation - Ongoing Clinical Trials

4.1 Trauma Fixation Companies - Pipeline Products by Stage of Development
4.2 Trauma Fixation - Pipeline Products by Stage of Development

5.1 206 Ortho, Inc. Company Overview
5.1.1 206 Ortho, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 4WEB Medical Inc Company Overview
5.2.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 aap Implantate AG Company Overview
5.3.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
5.4 Acuitive Technologies Inc Company Overview
5.4.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Advanced BioMedical Technologies, Inc. Company Overview
5.5.1 Advanced BioMedical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 AMB Surgical II LLC Company Overview
5.6.1 AMB Surgical II LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Apex Biomedical LLC Company Overview
5.7.1 Apex Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Appiades Meditech ltd. Company Overview
5.8.1 Appiades Meditech ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Argomedical AG Company Overview
5.9.1 Argomedical AG Pipeline Products & Ongoing Clinical Trials Overview
5.10 Ascendx Spine, Inc. (Inactive) Company Overview
5.10.1 Ascendx Spine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 B1 Medical Ltd (Inactive) Company Overview
5.11.1 B1 Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.12 Bactiguard Holding AB Company Overview
5.12.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
5.13 BioMagnesium Systems Ltd. (Inactive) Company Overview
5.13.1 BioMagnesium Systems Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Bioretec Ltd Company Overview
5.14.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Body Organ Biomedical Corp Company Overview
5.15.1 Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 Camber Spine Technologies LLC Company Overview
5.16.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 CAMBfix Ltd (Inactive) Company Overview
5.17.1 CAMBfix Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.18 Cardinal Health Inc Company Overview
5.18.1 Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Clear Surgical Ltd Company Overview
5.19.1 Clear Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Clemson University Company Overview
5.20.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Columbia University Company Overview
5.21.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.22 Conventus Orthopaedics Company Overview
5.22.1 Conventus Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview
5.23 Coracoid Solutions LLC Company Overview
5.23.1 Coracoid Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 Curtin University Company Overview
5.24.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview
5.25 Dallen Medical Company Overview
5.25.1 Dallen Medical Pipeline Products & Ongoing Clinical Trials Overview
5.26 DePuy Synthes Inc Company Overview
5.26.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Drexel University Company Overview
5.27.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
5.28 DSM Biomedical BV Company Overview
5.28.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
5.29 Dynamic Memory Medical Technologies Ltd. Company Overview
5.29.1 Dynamic Memory Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Endoorthopaedics, Inc. Company Overview
5.30.1 Endoorthopaedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 Evonik Corp Company Overview
5.31.1 Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview
5.32 Expanding Orthopedics Inc Company Overview
5.32.1 Expanding Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 ExsoMed Corp Company Overview
5.33.1 ExsoMed Corp Pipeline Products & Ongoing Clinical Trials Overview
5.34 FH Industrie Company Overview
5.34.1 FH Industrie Pipeline Products & Ongoing Clinical Trials Overview
5.35 Gramercy Extremity Orthopedics LLC Company Overview
5.35.1 Gramercy Extremity Orthopedics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 Hannover Medical School Company Overview
5.36.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
5.37 Hospital for Special Surgery Company Overview
5.37.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
5.38 Implants International Ltd Company Overview
5.38.1 Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 Innovia LLC Company Overview
5.39.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.40 Interface Biologics Inc Company Overview
5.40.1 Interface Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 Intramed Systems Ltd Company Overview
5.41.1 Intramed Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Johns Hopkins University Company Overview
5.42.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.43 Koc Universitesi Company Overview
5.43.1 Koc Universitesi Pipeline Products & Ongoing Clinical Trials Overview
5.44 McGill University Company Overview
5.44.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.45 Medshape Inc Company Overview
5.45.1 Medshape Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 Medtronic Plc Company Overview
5.46.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Mel Frontier Co Ltd Company Overview
5.47.1 Mel Frontier Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.48 Meta Biomed Co Ltd Company Overview
5.48.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.49 MicroPort Scientific Corp Company Overview
5.49.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.50 Nagoya University Company Overview
5.50.1 Nagoya University Pipeline Products & Ongoing Clinical Trials Overview
5.51 Nanova, Inc Company Overview
5.51.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.52 Nasseo, Inc. Company Overview
5.52.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.53 NEOS Surgery SL Company Overview
5.53.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview
5.54 Nextremity Solutions, LLC. Company Overview
5.54.1 Nextremity Solutions, LLC. Pipeline Products & Ongoing Clinical Trials Overview
5.55 Nuortho Surgical Inc Company Overview
5.55.1 Nuortho Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 Nutek Orthopaedics Inc Company Overview
5.56.1 Nutek Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.57 OrthoMend Research Inc Company Overview
5.57.1 OrthoMend Research Inc Pipeline Products & Ongoing Clinical Trials Overview
5.58 OrthoPediatrics Corp Company Overview
5.58.1 OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.59 OrthoSensor Inc Company Overview
5.59.1 OrthoSensor Inc Pipeline Products & Ongoing Clinical Trials Overview
5.60 Orthospin Ltd Company Overview
5.60.1 Orthospin Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.61 Ossio Ltd Company Overview
5.61.1 Ossio Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.62 Osteo Pharma BV Company Overview
5.62.1 Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
5.63 Ostiio Company Overview
5.63.1 Ostiio Pipeline Products & Ongoing Clinical Trials Overview
5.64 PainTEQ Company Overview
5.64.1 PainTEQ Pipeline Products & Ongoing Clinical Trials Overview
5.65 Paragon 28 Inc Company Overview
5.65.1 Paragon 28 Inc Pipeline Products & Ongoing Clinical Trials Overview
5.66 Resoimplant GmbH (Inactive) Company Overview
5.66.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.67 Resorbium Ltd Company Overview
5.67.1 Resorbium Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.68 Response Ortho Company Overview
5.68.1 Response Ortho Pipeline Products & Ongoing Clinical Trials Overview
5.69 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview
5.69.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview
5.70 Saint Louis University Company Overview
5.70.1 Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview
5.71 Sayan Orthopaedics Ltd Company Overview
5.71.1 Sayan Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.72 SeaSpine, Inc. Company Overview
5.72.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.73 SINTX Technologies Inc Company Overview
5.73.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.74 Smith & Nephew Plc Company Overview
5.74.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
5.75 SpineSmith Holdings LLC Company Overview
5.75.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
5.76 Stryker Corp Company Overview
5.76.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview
5.77 SUNY Upstate Medical University Company Overview
5.77.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview
5.78 Synoste Oy Company Overview
5.78.1 Synoste Oy Pipeline Products & Ongoing Clinical Trials Overview
5.79 Syntellix AG Company Overview
5.79.1 Syntellix AG Pipeline Products & Ongoing Clinical Trials Overview
5.80 Teleflex Inc Company Overview
5.80.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.81 Tepha Inc Company Overview
5.81.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.82 Tesa Medical, Inc. Company Overview
5.82.1 Tesa Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.83 The Feinstein Institute for Medical Research Company Overview
5.83.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.84 The University of Nottingham Company Overview
5.84.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
5.85 Tornier Inc Company Overview
5.85.1 Tornier Inc Pipeline Products & Ongoing Clinical Trials Overview
5.86 Tyber Medical LLC Company Overview
5.86.1 Tyber Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.87 University of Alabama Company Overview
5.87.1 University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
5.88 University of Alabama at Birmingham Company Overview
5.88.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
5.89 University of Colorado Company Overview
5.89.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.90 University of Kansas Company Overview
5.90.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
5.91 University of Massachusetts Worcester Campus Company Overview
5.91.1 University of Massachusetts Worcester Campus Pipeline Products & Ongoing Clinical Trials Overview
5.92 University of Michigan Pediatric Device Consortium Company Overview
5.92.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
5.93 University of Nebraska Company Overview
5.93.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview
5.94 University of Nevada Reno Company Overview
5.94.1 University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview
5.95 University of North Carolina at Chapel Hill Company Overview
5.95.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
5.96 University of Oxford Company Overview
5.96.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.97 University of South Florida Company Overview
5.97.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.98 University of Texas Health Science Center at San Antonio Company Overview
5.98.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview
5.99 University of Texas Medical Branch at Galveston Company Overview
5.99.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.100 University of Texas Southwestern Medical Center Company Overview
5.100.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.101 University of Toledo Company Overview
5.101.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
5.102 University of Utah Company Overview
5.102.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.103 University of Washington Company Overview
5.103.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.104 Vertech Inc Company Overview
5.104.1 Vertech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.105 Wright Medical Group NV Company Overview
5.105.1 Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview
5.106 Yale University Company Overview
5.106.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview

6.1 Oct 06, 2020: Tyber Medical launches clinical study for titanium integrated interbody devices
6.2 Aug 13, 2020: Medline joins NPPGov as an approved vendor offering top-notch medical supplies
6.3 Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device
6.4 Jul 13, 2020: DSM appoints Cristina Monteiro new EVP People & Organization and member of the Executive Committee
6.5 Jul 02, 2020: Osteopore signs initial U.S. distribution agreement
6.6 Jul 01, 2020: DSM appoints Zhou Tao (Joe) as President DSM China
6.7 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
6.8 Jun 02, 2020: Evonik names new North America region chief
6.9 May 28, 2020: Conformis announces settlement of patent dispute
6.10 May 07, 2020: DSM to help accelerate Dutch Covid-19 testing by making 2.8 million nose swabs
6.11 Apr 27, 2020: SpineGuard strengthens its IP with the grant of three new patents
6.12 Apr 08, 2020: Wright Medical Group announces virtual meeting alternative to physical attendance at Extraordinary General Meeting of Shareholders and change of time and location of meeting
6.13 Mar 13, 2020: Ossio gets FDA clearance for OSSIOfiber Hammertoe Fixation System
6.14 Mar 04, 2020: TriMed, announces release of the ASET Foot Plating Systems
6.15 Mar 03, 2020: Treace Medical announces publication of clinical data supporting Lapiplasty 3D bunion correction
6.16 Mar 02, 2020: Stryker announces new Investor Relations leader
6.17 Feb 25, 2020: New study gets to the root of fixing pediatric flatfeet
6.18 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
6.19 Feb 25, 2020: DSM appoints new EVP Materials and member of the Executive Committee
6.20 Feb 24, 2020: Positive signs for further growth in Asia: Syntellix receives product approvals in Malaysia and Myanmar earlier than planned
6.21 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.22 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.23 Feb 20, 2020: Paragon 28 adds larger implant option to help address Hallux Malleus in their First-of-its-kind Hammertoe and Plantar Plate Repair Solution - TenoTac Soft Tissue Fixation System
6.24 Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance
6.25 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
6.26 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.27 Feb 14, 2020: SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation
6.28 Feb 13, 2020: Breakthrough study published measuring the effect of EOTTS to reduce Medial knee compartment forces
6.29 Feb 13, 2020: DSM reports 2019 results
6.30 Feb 12, 2020: 4WEB Medical Achieves Record Revenue in 2019
6.31 Feb 10, 2020: MedShape announces positive early results with the DynaNail Mini
6.32 Feb 07, 2020: Paratrooper Plantar Plate System receives 510(k) clearance - 1st dedicated system allowing surgeons to repair the plantar plate through either a dorsal or plantar approach
6.33 Feb 07, 2020: Paragon 28 Phantom ActivCore Nail System Receives 510(k) Clearance - Continuous Compression Hindfoot Nail System
6.34 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020
6.35 Feb 05, 2020: Stryker expands Flower Mound regional headquarters
6.36 Feb 04, 2020: AMDT Holdings initiates the launch of the SixFix Circular Fixation System
6.37 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
6.38 Jan 31, 2020: McGinley Orthopedics launches new plate for distal radius fractures: Lever Action Plate System
6.39 Jan 28, 2020: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants
6.40 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
6.41 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
6.42 Jan 23, 2020: Centinel Spine announces continued partnership with Performance Tech Motorsports
6.43 Jan 20, 2020: DSM names Feike Sijbesma Honorary Chairman
6.44 Jan 16, 2020: LimaCorporate inaugurates the new Research & Innovation Center for 3D printing and the Advanced Laboratory for Testing and Analysis (ATLAs)
6.45 Jan 15, 2020: MEDICREA reports 2019 annual sales
6.46 Jan 13, 2020: OrthoPediatrics reports preliminary unaudited revenue for fourth quarter and record setting full year 2019
6.47 Jan 13, 2020: NuVasive announces preliminary unaudited fourth quarter and full year 2019 revenue results
6.48 Jan 13, 2020: ATEC announces preliminary 2019 revenue results and 2020 revenue outlook
6.49 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
6.50 Jan 08, 2020: Globus Medical reports preliminary record fourth quarter and full year sales results
6.51 Jan 06, 2020: Nextremity Solutions receives FDA 510(k) clearance for Lesser Tarsometatarsal (TMT) Joint Arthrodesis System
6.52 Jan 06, 2020: Exactech announces leadership transition
6.53 Jan 02, 2020: NuVasive appoints Matthew K. Harbaugh as chief financial officer
6.54 Dec 23, 2019: Allegra receives funding through University of Sydney NHMRC grant
6.55 Dec 13, 2019: SI-BONE announces CIGNA establishes positive coverage for MIS SI joint fusion using the iFuse Implant System
6.56 Dec 13, 2019: Globus Medical announces Board of Director addition and departure
6.57 Dec 10, 2019: TriMed announces receipt of 483 closeout letter from FDA
6.58 Dec 09, 2019: Tyber Medical cuts ribbon on new $8 million office and manufacturing facility
6.59 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business
6.60 Dec 05, 2019: Ted Bird and David Gill join Bio2 Technologies Board of Directors
6.61 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.62 Dec 03, 2019: RTI Surgical accelerates business transformation with senior leadership appointments
6.63 Dec 03, 2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

Table 1: Trauma Fixation - Pipeline Products by Stage of Development
Table 2: Trauma Fixation - Pipeline Products by Segment
Table 3: Trauma Fixation - Pipeline Products by Territory
Table 4: Trauma Fixation - Pipeline Products by Regulatory Path
Table 5: Trauma Fixation - Pipeline Products by Estimated Approval Date
Table 6: Trauma Fixation - Ongoing Clinical Trials
Table 7: Trauma Fixation Companies - Pipeline Products by Stage of Development
Table 8: Trauma Fixation - Pipeline Products by Stage of Development
Table 9: 206 Ortho, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ortho Implant - Product Status
Table 11: Ortho Implant - Product Description
Table 12: 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Truss Implant - Trauma Procedures - Product Status
Table 14: Truss Implant - Trauma Procedures - Product Description
Table 15: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Loqteq Antibacterial Plate - Product Status
Table 17: Loqteq Antibacterial Plate - Product Description
Table 18: LOQTEQ VA Hook Plate 2.5 - Product Status
Table 19: LOQTEQ VA Hook Plate 2.5 - Product Description
Table 20: LOQTEQ VA L-Fusion Plate 2.5 - Product Status
Table 21: LOQTEQ VA L-Fusion Plate 2.5 - Product Description
Table 22: LOQTEQ VA Metatarsal L-Plate 2.5 - Product Status
Table 23: LOQTEQ VA Metatarsal L-Plate 2.5 - Product Description
Table 24: LOQTEQ VA Metatarsal Straight Plate 2.5 - Product Status
Table 25: LOQTEQ VA Metatarsal Straight Plate 2.5 - Product Description
Table 26: LOQTEQ VA Metatarsal T-Plate 2.5 - Product Status
Table 27: LOQTEQ VA Metatarsal T-Plate 2.5 - Product Description
Table 28: LOQTEQ VA MTP Fusion Plate 2.5 - Product Status
Table 29: LOQTEQ VA MTP Fusion Plate 2.5 - Product Description
Table 30: LOQTEQ VA MTP Revision Plate 2.5 - Product Status
Table 31: LOQTEQ VA MTP Revision Plate 2.5 - Product Description
Table 32: LOQTEQ VA Osteotomy Plate 2.5 - Product Status
Table 33: LOQTEQ VA Osteotomy Plate 2.5 - Product Description
Table 34: LOQTEQ VA Plantar Fusion Plate 2.5 - Product Status
Table 35: LOQTEQ VA Plantar Fusion Plate 2.5 - Product Description
Table 36: LOQTEQ VA Resorbable - Pin - Product Status
Table 37: LOQTEQ VA Resorbable - Pin - Product Description
Table 38: LOQTEQ VA Resorbable - Plate - Product Status
Table 39: LOQTEQ VA Resorbable - Plate - Product Description
Table 40: LOQTEQ VA Resorbable - Screw - Product Status
Table 41: LOQTEQ VA Resorbable - Screw - Product Description
Table 42: LOQTEQ VA Straight Fusion Plate 2.5 - Product Status
Table 43: LOQTEQ VA Straight Fusion Plate 2.5 - Product Description
Table 44: LOQTEQ VA Tibia Plates - Product Status
Table 45: LOQTEQ VA Tibia Plates - Product Description
Table 46: LOQTEQ VA X-Plate 2.5 - Product Status
Table 47: LOQTEQ VA X-Plate 2.5 - Product Description
Table 48: PMMA Augmented LOQTEQ Implant - Product Status
Table 49: PMMA Augmented LOQTEQ Implant - Product Description
Table 50: aap Implantate AG - Ongoing Clinical Trials Overview

Figure 1: Trauma Fixation - Pipeline Products by Stage of Development
Figure 2: Trauma Fixation - Pipeline Products by Segment
Figure 3: Trauma Fixation - Pipeline Products by Territory
Figure 4: Trauma Fixation - Pipeline Products by Regulatory Path
Figure 5: Trauma Fixation - Pipeline Products by Estimated Approval Date
Figure 6: Trauma Fixation - Ongoing Clinical Trials